Influence of oil droplet surface charge on the performance of antibody--emulsion conjugates.
暂无分享,去创建一个
S. Benita | S Benita | D Goldstein | O Sader | D. Goldstein | O. Sader
[1] R. Müller,et al. In vitro adsorption of plasma proteins onto the surface (charges) modified-submicron emulsions for intravenous administration. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[2] T. Allen,et al. Ligand-targeted liposomes for cancer treatment. , 2005, Current drug delivery.
[3] M. Bally,et al. The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations. , 2005, Current drug delivery.
[4] T. Allen,et al. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. , 1995, Biochimica et biophysica acta.
[5] U. Zangemeister‐Wittke. Antibodies for Targeted Cancer Therapy – Technical Aspects and Clinical Perspectives , 2006, Pathobiology.
[6] E. Papadimitriou,et al. Interactions of PC/Chol and PS/Chol Liposomes with Human Cells in Vitro , 2000, Journal of drug targeting.
[7] T M Allen,et al. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. , 1998, Cancer research.
[8] G. Griffiths,et al. Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphoma cells. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[9] M. Yokoyama,et al. Drug targeting with nano-sized carrier systems , 2005, Journal of Artificial Organs.
[10] Y K Song,et al. Antibody mediated lung targeting of long-circulating emulsions. , 1996, PDA journal of pharmaceutical science and technology.
[11] G. Griffiths,et al. Conjugation of an Anti‐B‐cell Lymphoma Monoclonal Antibody, LL2, to Long‐circulating Drug‐carrier Lipid Emulsions , 1999, The Journal of pharmacy and pharmacology.
[12] S. Benita,et al. The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[13] T. Allen,et al. Ligand-targeted liposomal anticancer drugs. , 2003, Progress in lipid research.
[14] V. Schirrmacher,et al. Tumour targeting with antibody-coupled liposomes: Failure to achieve accumulation in xenografts and spontaneous liver metastases , 1990, Cancer Immunology, Immunotherapy.
[15] I. Ahmad,et al. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. , 1992, Cancer research.
[16] Fumiyoshi Yamashita,et al. Lipid carrier systems for targeted drug and gene delivery. , 2005, Chemical & pharmaceutical bulletin.
[17] D. Papahadjopoulos,et al. Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. , 1993, Biochemistry.
[18] S. Benita,et al. Enhanced absorption and drug targeting by positively charged submicron emulsions , 2000 .
[19] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.